MANGIONI, COSTANTINO
 Distribuzione geografica
Continente #
NA - Nord America 2325
EU - Europa 847
AS - Asia 203
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3383
Nazione #
US - Stati Uniti d'America 2294
SE - Svezia 260
DE - Germania 210
IT - Italia 144
CN - Cina 125
UA - Ucraina 75
IE - Irlanda 50
VN - Vietnam 40
GB - Regno Unito 36
CA - Canada 31
IN - India 16
DK - Danimarca 14
FI - Finlandia 13
FR - Francia 12
AT - Austria 9
TR - Turchia 9
RU - Federazione Russa 8
IR - Iran 5
RO - Romania 5
JP - Giappone 4
NL - Olanda 4
MU - Mauritius 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BR - Brasile 1
EU - Europa 1
HU - Ungheria 1
PL - Polonia 1
Totale 3383
Città #
Ann Arbor 368
Fairfield 308
Chandler 251
Woodbridge 234
Frankfurt am Main 194
Houston 165
Wilmington 132
Ashburn 116
Seattle 105
Cambridge 100
Princeton 96
Jacksonville 70
Dearborn 57
Dublin 50
Lawrence 44
Milan 42
Altamura 35
Beijing 27
Dong Ket 24
Fremont 24
San Diego 24
Nanjing 23
Andover 19
Guangzhou 17
Toronto 13
Falls Church 11
Lachine 11
Hebei 9
London 9
Vienna 9
Shenyang 8
Nanchang 7
Boardman 6
Norwalk 6
Lissone 5
Torre Del Greco 5
Changsha 4
Laurel 4
Ningbo 4
Ottawa 4
Saint Petersburg 4
Sestri Levante 4
Tianjin 4
Zhengzhou 4
Castelleone 3
Edmonton 3
Jiaxing 3
Mountain View 3
Redmond 3
Rome 3
San Mateo 3
Tokyo 3
Amsterdam 2
Bangalore 2
Bangkok 2
Cusano Milanino 2
Dubai 2
Genova 2
Grottaglie 2
Hangzhou 2
Kardzhali 2
Kunming 2
Los Angeles 2
Portland 2
Rovato 2
Sacramento 2
Taizhou 2
Trieste 2
Anaheim 1
Brugherio 1
Brussels 1
Cirié 1
Codogno 1
Cupertino 1
Grafing 1
Harbin 1
Hefei 1
Helsinki 1
Huzhou 1
Jinan 1
Kiev 1
Las Vegas 1
Legnano 1
Mumbai 1
New York 1
Perugia 1
Raleigh 1
Reghin 1
San Francisco 1
San Marco Evangelista 1
Sarego 1
Segrate 1
Shaoxing 1
Solliès-pont 1
Swindon 1
São Paulo 1
Taiyuan 1
Trento 1
Udine 1
Varazze 1
Totale 2744
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 425
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 264
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial 139
Survival and reproductive function after treatment of malignant germ cell ovarian tumors 134
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 131
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 128
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 127
Treatment of advanced ovarian cancer (OC): A randomized trial comparing different platinum (P) combinations 115
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 115
Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women 108
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 104
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities 104
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 84
Flow cytometric DNA content analysis in 708 patients affected by ovarian cancer. Clinical correlations 79
Flow cytometric analysis of DNA content in human ovarian cancers 72
DNA interstrand cross-links induced by cis-dichlorodiammine platinum in ovarian cancer cells growing in primary culture 70
Mitozolomide activity on human cancer cells in vitro 70
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 70
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 66
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 64
Evaluation of the interaction of mononuclear phagocytes with ovarian carcinoma cells in a colony assay 63
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin 61
EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT) 60
Autologous blood transfusion in patients undergoing radical hysterectomy 53
Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary 52
Steroid Receptors in Epithelial Ovarian Carcinoma: Relation to Clinical Parameters And Survival 47
A role for tumor markers in therapeutic decisions after chemotherapy induction of objective remission in stage III epithelial ovarian neoplasms 47
Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma 47
Cefotetan versus piperacillin in the prophylaxis of abdominal and vaginal hysterectomy: a prospective randomized study 44
Interferon-β can induce progesterone receptors in human endometrial adenocarcinoma 44
[Controlled clinical study of ceftezol in the prevention of infections in obstetrico-gynecologic surgery] 44
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study 43
Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy 43
Antibiotic prophylaxis of infection after gynecologic surgery: a prospective randomized trial between cefotetan and piperacillin 40
Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine 40
Are borderline tumors of the ovary safely treated by laparoscopy? 40
Neoplasie dell'ovaio 40
Bleomycin, ifosfamide and cis-platin chemotherapy in recurrent and persistent cervical cancer, a prospective study 39
Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma 38
I tumori dell'ovaio 36
Neoplasie dell'ovaio 35
Cancer of the cervix, FIGO stages IB and IIA: Patterns of local growth and paracervical extension 33
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial 32
Concurrent platinum-based chemo- and radiotherapy for locally advanced cervical cancer: A new gold-standard treatment? 31
Concurrent carboplatin/5FU and radiotherapy compared to radiotherapy alone in locally advanced cervical carcinoma: a case-control study 31
Brain metastases from cervical carcinoma 27
Trattamento del carcinoma della cervice uterina stadio IIIB. Confronto tra radioterapia, chemio-radioterapia concomitante e chemioterapia neoadiuvante [Treatment of stage IIIB cervical carcinoma. A comparison between radiotherapy, concurrent chemo-radiotherapy and neoadjuvant chemotherapy] 25
La terapia chirurgica del carcinoma della vulva. 11
Totale 3615
Categoria #
all - tutte 6676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201812 0000 00 00 2154
2018/2019212 3411 119 139 9265670
2019/2020791 57203748 5162 6738 223977714
2020/2021708 55359648 5165 7941 67465867
2021/2022597 185910035 4436 2636 233763120
2022/2023951 1303077685 71155 1441 72000
Totale 3615